Global Monkeypox Treatment Market Growth (Status and Outlook) 2026-2032

May 2026 | 118 pages | ID: G5BFD7F9D12FEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Monkeypox Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Monkeypox (mpox) is a viral infection that spreads from animals to humans, hence it is called a zoonotic infection. The recent outbreak of mpox on May 6, 2022. The human mpox virus was initially identified in 1970 in the Democratic Republic of Congo. The source of the virus is unknown; however, the first six monkeypox cases were found in the UK. Fever, swelling in the lymph nodes, rashes on the skin, chills, muscle fatigue, headache, backache, and respiratory symptoms such as sore throat, cough, and congestion are the common symptoms of monkeypox infection. The virus is transmitted sexually or through touch. The disease has claimed the lives of some people. People with weak immunity, breastfeeding mothers, women during pregnancy, children below the age of 10 years, and people having prolonged exposure to the infected animal are susceptible to the viral infection.

United States market for Monkeypox Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Monkeypox Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Monkeypox Treatment is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Monkeypox Treatment players cover Bavarian Nordic, Chimerix, Inc., CIDIC Company Limited, Emcure Pharmaceuticals, Emergent, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “Monkeypox Treatment Industry Forecast” looks at past sales and reviews total world Monkeypox Treatment sales in 2025, providing a comprehensive analysis by region and market sector of projected Monkeypox Treatment sales for 2026 through 2032. With Monkeypox Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monkeypox Treatment industry.

This Insight Report provides a comprehensive analysis of the global Monkeypox Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Monkeypox Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Monkeypox Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monkeypox Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monkeypox Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Monkeypox Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Oral
  • Injectable
Segmentation by Application:
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Bavarian Nordic
  • Chimerix, Inc.
  • CIDIC Company Limited
  • Emcure Pharmaceuticals
  • Emergent
  • Gilead Sciences Inc.
  • Hetero Drugs Limited
  • Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
  • Mylan N.V.
  • Olon S.p.A.
  • Piramal Pharma Solutions
  • SIGA Technologies Inc.
  • Sonofi SA
  • Teva Pharmaceutical Industries Limited
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Monkeypox Treatment Market Size (2021-2032)
  2.1.2 Monkeypox Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Monkeypox Treatment by Country/Region (2021, 2025 & 2032)
2.2 Monkeypox Treatment Segment by Type
  2.2.1 Oral
  2.2.2 Injectable
  2.2.3 Monkeypox Treatment Market Size by Type
    2.2.3.1 Monkeypox Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Monkeypox Treatment Market Size Market Share by Type (2021-2026)
2.3 Monkeypox Treatment Segment by Application
  2.3.1 Hospital Pharmacy
  2.3.2 Online Pharmacy
  2.3.3 Retail Pharmacy
  2.3.4 Monkeypox Treatment Market Size by Application
    2.3.4.1 Monkeypox Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Monkeypox Treatment Market Size Market Share by Application (2021-2026)

3 MONKEYPOX TREATMENT MARKET SIZE BY PLAYER

3.1 Monkeypox Treatment Market Size Market Share by Player
  3.1.1 Global Monkeypox Treatment Revenue by Player (2021-2026)
  3.1.2 Global Monkeypox Treatment Revenue Market Share by Player (2021-2026)
3.2 Global Monkeypox Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MONKEYPOX TREATMENT BY REGION

4.1 Monkeypox Treatment Market Size by Region (2021-2026)
4.2 Global Monkeypox Treatment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Monkeypox Treatment Market Size Growth (2021-2026)
4.4 APAC Monkeypox Treatment Market Size Growth (2021-2026)
4.5 Europe Monkeypox Treatment Market Size Growth (2021-2026)
4.6 Middle East & Africa Monkeypox Treatment Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Monkeypox Treatment Market Size by Country (2021-2026)
5.2 Americas Monkeypox Treatment Market Size by Type (2021-2026)
5.3 Americas Monkeypox Treatment Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Monkeypox Treatment Market Size by Region (2021-2026)
6.2 APAC Monkeypox Treatment Market Size by Type (2021-2026)
6.3 APAC Monkeypox Treatment Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Monkeypox Treatment Market Size by Country (2021-2026)
7.2 Europe Monkeypox Treatment Market Size by Type (2021-2026)
7.3 Europe Monkeypox Treatment Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Monkeypox Treatment by Region (2021-2026)
8.2 Middle East & Africa Monkeypox Treatment Market Size by Type (2021-2026)
8.3 Middle East & Africa Monkeypox Treatment Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MONKEYPOX TREATMENT MARKET FORECAST

10.1 Global Monkeypox Treatment Forecast by Region (2027-2032)
  10.1.1 Global Monkeypox Treatment Forecast by Region (2027-2032)
  10.1.2 Americas Monkeypox Treatment Forecast
  10.1.3 APAC Monkeypox Treatment Forecast
  10.1.4 Europe Monkeypox Treatment Forecast
  10.1.5 Middle East & Africa Monkeypox Treatment Forecast
10.2 Americas Monkeypox Treatment Forecast by Country (2027-2032)
  10.2.1 United States Market Monkeypox Treatment Forecast
  10.2.2 Canada Market Monkeypox Treatment Forecast
  10.2.3 Mexico Market Monkeypox Treatment Forecast
  10.2.4 Brazil Market Monkeypox Treatment Forecast
10.3 APAC Monkeypox Treatment Forecast by Region (2027-2032)
  10.3.1 China Monkeypox Treatment Market Forecast
  10.3.2 Japan Market Monkeypox Treatment Forecast
  10.3.3 Korea Market Monkeypox Treatment Forecast
  10.3.4 Southeast Asia Market Monkeypox Treatment Forecast
  10.3.5 India Market Monkeypox Treatment Forecast
  10.3.6 Australia Market Monkeypox Treatment Forecast
10.4 Europe Monkeypox Treatment Forecast by Country (2027-2032)
  10.4.1 Germany Market Monkeypox Treatment Forecast
  10.4.2 France Market Monkeypox Treatment Forecast
  10.4.3 UK Market Monkeypox Treatment Forecast
  10.4.4 Italy Market Monkeypox Treatment Forecast
  10.4.5 Russia Market Monkeypox Treatment Forecast
10.5 Middle East & Africa Monkeypox Treatment Forecast by Region (2027-2032)
  10.5.1 Egypt Market Monkeypox Treatment Forecast
  10.5.2 South Africa Market Monkeypox Treatment Forecast
  10.5.3 Israel Market Monkeypox Treatment Forecast
  10.5.4 Turkey Market Monkeypox Treatment Forecast
10.6 Global Monkeypox Treatment Forecast by Type (2027-2032)
10.7 Global Monkeypox Treatment Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Monkeypox Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Bavarian Nordic
  11.1.1 Bavarian Nordic Company Information
  11.1.2 Bavarian Nordic Monkeypox Treatment Product Offered
  11.1.3 Bavarian Nordic Monkeypox Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Bavarian Nordic Main Business Overview
  11.1.5 Bavarian Nordic Latest Developments
11.2 Chimerix, Inc.
  11.2.1 Chimerix, Inc. Company Information
  11.2.2 Chimerix, Inc. Monkeypox Treatment Product Offered
  11.2.3 Chimerix, Inc. Monkeypox Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Chimerix, Inc. Main Business Overview
  11.2.5 Chimerix, Inc. Latest Developments
11.3 CIDIC Company Limited
  11.3.1 CIDIC Company Limited Company Information
  11.3.2 CIDIC Company Limited Monkeypox Treatment Product Offered
  11.3.3 CIDIC Company Limited Monkeypox Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 CIDIC Company Limited Main Business Overview
  11.3.5 CIDIC Company Limited Latest Developments
11.4 Emcure Pharmaceuticals
  11.4.1 Emcure Pharmaceuticals Company Information
  11.4.2 Emcure Pharmaceuticals Monkeypox Treatment Product Offered
  11.4.3 Emcure Pharmaceuticals Monkeypox Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Emcure Pharmaceuticals Main Business Overview
  11.4.5 Emcure Pharmaceuticals Latest Developments
11.5 Emergent
  11.5.1 Emergent Company Information
  11.5.2 Emergent Monkeypox Treatment Product Offered
  11.5.3 Emergent Monkeypox Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Emergent Main Business Overview
  11.5.5 Emergent Latest Developments
11.6 Gilead Sciences Inc.
  11.6.1 Gilead Sciences Inc. Company Information
  11.6.2 Gilead Sciences Inc. Monkeypox Treatment Product Offered
  11.6.3 Gilead Sciences Inc. Monkeypox Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Gilead Sciences Inc. Main Business Overview
  11.6.5 Gilead Sciences Inc. Latest Developments
11.7 Hetero Drugs Limited
  11.7.1 Hetero Drugs Limited Company Information
  11.7.2 Hetero Drugs Limited Monkeypox Treatment Product Offered
  11.7.3 Hetero Drugs Limited Monkeypox Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Hetero Drugs Limited Main Business Overview
  11.7.5 Hetero Drugs Limited Latest Developments
11.8 Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
  11.8.1 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Company Information
  11.8.2 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Product Offered
  11.8.3 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Main Business Overview
  11.8.5 Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Latest Developments
11.9 Mylan N.V.
  11.9.1 Mylan N.V. Company Information
  11.9.2 Mylan N.V. Monkeypox Treatment Product Offered
  11.9.3 Mylan N.V. Monkeypox Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Mylan N.V. Main Business Overview
  11.9.5 Mylan N.V. Latest Developments
11.10 Olon S.p.A.
  11.10.1 Olon S.p.A. Company Information
  11.10.2 Olon S.p.A. Monkeypox Treatment Product Offered
  11.10.3 Olon S.p.A. Monkeypox Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Olon S.p.A. Main Business Overview
  11.10.5 Olon S.p.A. Latest Developments
11.11 Piramal Pharma Solutions
  11.11.1 Piramal Pharma Solutions Company Information
  11.11.2 Piramal Pharma Solutions Monkeypox Treatment Product Offered
  11.11.3 Piramal Pharma Solutions Monkeypox Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Piramal Pharma Solutions Main Business Overview
  11.11.5 Piramal Pharma Solutions Latest Developments
11.12 SIGA Technologies Inc.
  11.12.1 SIGA Technologies Inc. Company Information
  11.12.2 SIGA Technologies Inc. Monkeypox Treatment Product Offered
  11.12.3 SIGA Technologies Inc. Monkeypox Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 SIGA Technologies Inc. Main Business Overview
  11.12.5 SIGA Technologies Inc. Latest Developments
11.13 Sonofi SA
  11.13.1 Sonofi SA Company Information
  11.13.2 Sonofi SA Monkeypox Treatment Product Offered
  11.13.3 Sonofi SA Monkeypox Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 Sonofi SA Main Business Overview
  11.13.5 Sonofi SA Latest Developments
11.14 Teva Pharmaceutical Industries Limited
  11.14.1 Teva Pharmaceutical Industries Limited Company Information
  11.14.2 Teva Pharmaceutical Industries Limited Monkeypox Treatment Product Offered
  11.14.3 Teva Pharmaceutical Industries Limited Monkeypox Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.14.4 Teva Pharmaceutical Industries Limited Main Business Overview
  11.14.5 Teva Pharmaceutical Industries Limited Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Monkeypox Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Monkeypox Treatment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injectable
Table 5. Monkeypox Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Monkeypox Treatment Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Monkeypox Treatment Market Size Market Share by Type (2021-2026)
Table 8. Monkeypox Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Monkeypox Treatment Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Monkeypox Treatment Market Size Market Share by Application (2021-2026)
Table 11. Global Monkeypox Treatment Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Monkeypox Treatment Revenue Market Share by Player (2021-2026)
Table 13. Monkeypox Treatment Key Players Head office and Products Offered
Table 14. Monkeypox Treatment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Monkeypox Treatment Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Monkeypox Treatment Market Size Market Share by Region (2021-2026)
Table 19. Global Monkeypox Treatment Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Monkeypox Treatment Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Monkeypox Treatment Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Monkeypox Treatment Market Size Market Share by Country (2021-2026)
Table 23. Americas Monkeypox Treatment Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Monkeypox Treatment Market Size Market Share by Type (2021-2026)
Table 25. Americas Monkeypox Treatment Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Monkeypox Treatment Market Size Market Share by Application (2021-2026)
Table 27. APAC Monkeypox Treatment Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Monkeypox Treatment Market Size Market Share by Region (2021-2026)
Table 29. APAC Monkeypox Treatment Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Monkeypox Treatment Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Monkeypox Treatment Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Monkeypox Treatment Market Size Market Share by Country (2021-2026)
Table 33. Europe Monkeypox Treatment Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Monkeypox Treatment Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Monkeypox Treatment Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Monkeypox Treatment Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Monkeypox Treatment Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Monkeypox Treatment
Table 39. Key Market Challenges & Risks of Monkeypox Treatment
Table 40. Key Industry Trends of Monkeypox Treatment
Table 41. Global Monkeypox Treatment Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Monkeypox Treatment Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Monkeypox Treatment Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Monkeypox Treatment Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Bavarian Nordic Details, Company Type, Monkeypox Treatment Area Served and Its Competitors
Table 46. Bavarian Nordic Monkeypox Treatment Product Offered
Table 47. Bavarian Nordic Monkeypox Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Bavarian Nordic Main Business
Table 49. Bavarian Nordic Latest Developments
Table 50. Chimerix, Inc. Details, Company Type, Monkeypox Treatment Area Served and Its Competitors
Table 51. Chimerix, Inc. Monkeypox Treatment Product Offered
Table 52. Chimerix, Inc. Monkeypox Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Chimerix, Inc. Main Business
Table 54. Chimerix, Inc. Latest Developments
Table 55. CIDIC Company Limited Details, Company Type, Monkeypox Treatment Area Served and Its Competitors
Table 56. CIDIC Company Limited Monkeypox Treatment Product Offered
Table 57. CIDIC Company Limited Monkeypox Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. CIDIC Company Limited Main Business
Table 59. CIDIC Company Limited Latest Developments
Table 60. Emcure Pharmaceuticals Details, Company Type, Monkeypox Treatment Area Served and Its Competitors
Table 61. Emcure Pharmaceuticals Monkeypox Treatment Product Offered
Table 62. Emcure Pharmaceuticals Monkeypox Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Emcure Pharmaceuticals Main Business
Table 64. Emcure Pharmaceuticals Latest Developments
Table 65. Emergent Details, Company Type, Monkeypox Treatment Area Served and Its Competitors
Table 66. Emergent Monkeypox Treatment Product Offered
Table 67. Emergent Monkeypox Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Emergent Main Business
Table 69. Emergent Latest Developments
Table 70. Gilead Sciences Inc. Details, Company Type, Monkeypox Treatment Area Served and Its Competitors
Table 71. Gilead Sciences Inc. Monkeypox Treatment Product Offered
Table 72. Gilead Sciences Inc. Monkeypox Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Gilead Sciences Inc. Main Business
Table 74. Gilead Sciences Inc. Latest Developments
Table 75. Hetero Drugs Limited Details, Company Type, Monkeypox Treatment Area Served and Its Competitors
Table 76. Hetero Drugs Limited Monkeypox Treatment Product Offered
Table 77. Hetero Drugs Limited Monkeypox Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Hetero Drugs Limited Main Business
Table 79. Hetero Drugs Limited Latest Developments
Table 80. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Details, Company Type, Monkeypox Treatment Area Served and Its Competitors
Table 81. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Product Offered
Table 82. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Monkeypox Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Main Business
Table 84. Jinan Jinda Pharmaceutical Chemistry Co. Ltd. Latest Developments
Table 85. Mylan N.V. Details, Company Type, Monkeypox Treatment Area Served and Its Competitors
Table 86. Mylan N.V. Monkeypox Treatment Product Offered
Table 87. Mylan N.V. Monkeypox Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Mylan N.V. Main Business
Table 89. Mylan N.V. Latest Developments
Table 90. Olon S.p.A. Details, Company Type, Monkeypox Treatment Area Served and Its Competitors
Table 91. Olon S.p.A. Monkeypox Treatment Product Offered
Table 92. Olon S.p.A. Monkeypox Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Olon S.p.A. Main Business
Table 94. Olon S.p.A. Latest Developments
Table 95. Piramal Pharma Solutions Details, Company Type, Monkeypox Treatment Area Served and Its Competitors
Table 96. Piramal Pharma Solutions Monkeypox Treatment Product Offered
Table 97. Piramal Pharma Solutions Monkeypox Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Piramal Pharma Solutions Main Business
Table 99. Piramal Pharma Solutions Latest Developments
Table 100. SIGA Technologies Inc. Details, Company Type, Monkeypox Treatment Area Served and Its Competitors
Table 101. SIGA Technologies Inc. Monkeypox Treatment Product Offered
Table 102. SIGA Technologies Inc. Monkeypox Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. SIGA Technologies Inc. Main Business
Table 104. SIGA Technologies Inc. Latest Developments
Table 105. Sonofi SA Details, Company Type, Monkeypox Treatment Area Served and Its Competitors
Table 106. Sonofi SA Monkeypox Treatment Product Offered
Table 107. Sonofi SA Monkeypox Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Sonofi SA Main Business
Table 109. Sonofi SA Latest Developments
Table 110. Teva Pharmaceutical Industries Limited Details, Company Type, Monkeypox Treatment Area Served and Its Competitors
Table 111. Teva Pharmaceutical Industries Limited Monkeypox Treatment Product Offered
Table 112. Teva Pharmaceutical Industries Limited Monkeypox Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Teva Pharmaceutical Industries Limited Main Business
Table 114. Teva Pharmaceutical Industries Limited Latest Developments

LIST OF FIGURES

Figure 1. Monkeypox Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Monkeypox Treatment Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Monkeypox Treatment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Monkeypox Treatment Sales Market Share by Country/Region (2025)
Figure 8. Monkeypox Treatment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Monkeypox Treatment Market Size Market Share by Type in 2025
Figure 10. Monkeypox Treatment in Hospital Pharmacy
Figure 11. Global Monkeypox Treatment Market: Hospital Pharmacy (2021-2026) & ($ millions)
Figure 12. Monkeypox Treatment in Online Pharmacy
Figure 13. Global Monkeypox Treatment Market: Online Pharmacy (2021-2026) & ($ millions)
Figure 14. Monkeypox Treatment in Retail Pharmacy
Figure 15. Global Monkeypox Treatment Market: Retail Pharmacy (2021-2026) & ($ millions)
Figure 16. Global Monkeypox Treatment Market Size Market Share by Application in 2025
Figure 17. Global Monkeypox Treatment Revenue Market Share by Player in 2025
Figure 18. Global Monkeypox Treatment Market Size Market Share by Region (2021-2026)
Figure 19. Americas Monkeypox Treatment Market Size 2021-2026 ($ millions)
Figure 20. APAC Monkeypox Treatment Market Size 2021-2026 ($ millions)
Figure 21. Europe Monkeypox Treatment Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Monkeypox Treatment Market Size 2021-2026 ($ millions)
Figure 23. Americas Monkeypox Treatment Value Market Share by Country in 2025
Figure 24. United States Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Monkeypox Treatment Market Size Market Share by Region in 2025
Figure 29. APAC Monkeypox Treatment Market Size Market Share by Type (2021-2026)
Figure 30. APAC Monkeypox Treatment Market Size Market Share by Application (2021-2026)
Figure 31. China Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 35. India Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Monkeypox Treatment Market Size Market Share by Country in 2025
Figure 38. Europe Monkeypox Treatment Market Size Market Share by Type (2021-2026)
Figure 39. Europe Monkeypox Treatment Market Size Market Share by Application (2021-2026)
Figure 40. Germany Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 41. France Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Monkeypox Treatment Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Monkeypox Treatment Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Monkeypox Treatment Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Monkeypox Treatment Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 54. APAC Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 55. Europe Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 57. United States Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 58. Canada Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 59. Mexico Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 60. Brazil Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 61. China Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 62. Japan Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 63. Korea Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 65. India Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 66. Australia Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 67. Germany Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 68. France Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 69. UK Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 70. Italy Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 71. Russia Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 72. Egypt Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 73. South Africa Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 74. Israel Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 75. Turkey Monkeypox Treatment Market Size 2027-2032 ($ millions)
Figure 76. Global Monkeypox Treatment Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Monkeypox Treatment Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Monkeypox Treatment Market Size 2027-2032 ($ millions)


More Publications